Filter
Exclude
Time range
-
Near
SHUKRA PHARMACEUTICALS Q3 RESULT๐Ÿ’ช SL NET PROFIT 203M RUPEES VS 32M (YOY) REVENUE 391M RUPEES VS 106M (YOY) EBITDA 271M RUPEES VS 39M (YOY) EBITDA MARGIN 69.32% VS 37.20% (YOY) EXCELLENT RESULT #shukrapharma #StockMarketIndia #nifty50 #sensex #trading #Q3Results #q3fy26
3
229